Webinars and Videos
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Simulation Guided Trial Design: A Phase 2 Platform Screening Trial
Designing a platform trial to test several assets in the same indication that will become available over time.
Simulation Guided Trial Design: Phase 2 Subgroups
Designing a phase 2 trial to determine for which of four rare tumours a treatment is effective. Looking at separate analyses, pooled analysis and using a hierarchical model to borrow across groups.
75: Mammograms: Death Threats, Hillary Clinton and Lead-Time Bias
In this episode of "In the Interim…", Dr. Don Berry provides a detailed account of co-chairing the 1997 NIH consensus development conference on mammography for women in their 40s.
74: REMAP-CAP Results: Oseltamivir in Critically-Ill Influenza Patients
In this episode of "In the Interim…", Dr. Scott Berry speaks with Dr. Srinivas Murthy, Dr. Thomas Hills, and Dr. Lindsay Berry about the REMAP-CAP trial results on oseltamivir in critically ill influenza patients.
73: ICECAP: The Results
In this episode of "In the Interim…", Dr. Scott Berry leads a comprehensive discussion of the ICECAP trial results with four Principal Investigators.
72: Failure of the Proportional Odds is the Result
In this episode of "In the Interim…", Dr. Scott Berry and Dr. Elizabeth Lorenzi systematically examine the analytic pitfalls in recent acute ischemic stroke trials, especially the implications of violating the proportional odds assumption on the modified Rankin Scale.
No results found.
There are no results with this criteria. Try changing your search.